Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach

BACKGROUND AND AIMS: The heterogeneity of intermediate‐stage hepatocellular carcinoma (HCC) and the widespread use of transarterial chemoembolization (TACE) outside recommended guidelines have encouraged the development of scoring systems that predict patient survival. The aim of this study was to b...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony W. H., Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel, Pinato, David J., Sharma, Rohini, Ottaviani, Diego, Jang, Jeong W., Labeur, Tim A., van Delden, Otto M., Pirisi, Mario, Stern, Nick, Sangro, Bruno, Meyer, Tim, Fateen, Waleed, García‐Fiñana, Marta, Gomaa, Asmaa, Waked, Imam, Rewisha, Eman, Aithal, Guru P., Travis, Simon, Kudo, Masatoshi, Cucchetti, Alessandro, Peck‐Radosavljevic, Markus, Takkenberg, R.B., Chan, Stephen L., Vogel, Arndt, Johnson, Philip J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496334/
https://www.ncbi.nlm.nih.gov/pubmed/31698504
http://dx.doi.org/10.1002/hep.31022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496334/
https://www.ncbi.nlm.nih.gov/pubmed/31698504
http://dx.doi.org/10.1002/hep.31022

Ejemplares similares